MOHAMED HEGAZY to Remission Induction
This is a "connection" page, showing publications MOHAMED HEGAZY has written about Remission Induction.
Connection Strength
0.057
-
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. Semin Arthritis Rheum. 2026 Oct; 80:153030.
Score: 0.057